We are pleased to announce that 7 of our PIs received funding from the CIHR Project Grant Fall 2022 competition for their respective research projects. The national success rate for this competition was 20.1%; the Quebec provincial success rate was 23.7%; and the success rate of the GCI was 57%.
Congratulations to GCI Professors Luke McCaffrey, William Muller, Arnim Pause, Jerry Pelletier, Peter Siegel, Jose Teodoro and Ian Watson, who received a combined $6,035,661, either from a Project Grant or Bridge funding.
Projects Include:
Luke McCaffrey:ÌýCharacterizing tissue-intrinsic barriers to malignant transformation in the breast epithelium
William Muller: The multifaceted role of c-Src tyrosine kinase in breast cancer progression;ÌýChi3L1 (YKL-40) plays a multifaceted role in modulating tumour immune microenvironment during breast cancer progression (Bridge)
Arnim Pause:ÌýCharacterization of human TFE3 isoforms as drivers in breast cancerÌý(Bridge)
Jerry Pelletier:ÌýEukaryotic Initiation Factor 4F - A Strategic Driver of the Cellular Information Network
Peter Siegel:ÌýDefining the immunomodulatory role of GPNMB in triple-negative breast cancer
Jose Teodoro:ÌýTargeting the Ï㽶ÊÓƵ translatome to enhance anti-mitotic chemotherapyÌý(Bridge)
Ian Watson:ÌýIdentification of biomarkers using single cell technology that inform on optimal duration of immunotherapy treatment in melanoma